Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences

Oxidative Medicine and Cellular Longevity
Aline V N BacurauPatricia C Brum

Abstract

Skeletal myopathy has been identified as a major comorbidity of heart failure (HF) affecting up to 20% of ambulatory patients leading to shortness of breath, early fatigue, and exercise intolerance. Neurohumoral blockade, through the inhibition of renin angiotensin aldosterone system (RAS) and β-adrenergic receptor blockade (β-blockers), is a mandatory pharmacological therapy of HF since it reduces symptoms, mortality, and sudden death. However, the effect of these drugs on skeletal myopathy needs to be clarified, since exercise intolerance remains in HF patients optimized with β-blockers and inhibitors of RAS. Aerobic exercise training (AET) is efficient in counteracting skeletal myopathy and in improving functional capacity and quality of life. Indeed, AET has beneficial effects on failing heart itself despite being of less magnitude compared with neurohumoral blockade. In this way, AET should be implemented in the care standards, together with pharmacological therapies. Since both neurohumoral inhibition and AET have a direct and/or indirect impact on skeletal muscle, this review aims to provide an overview of the isolated effects of these therapeutic approaches in counteracting skeletal myopathy in HF. The similarities and ...Continue Reading

References

Jun 1, 1992·Cardiovascular Drugs and Therapy·L M Van Bortel, M A van Baak
Jan 1, 1992·Journal of Animal Science·Y S KimP Molenaar
Oct 9, 1991·Biochemical Pharmacology·Y S KimR J Summers
Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Jan 1, 1989·British Journal of Clinical Pharmacology·M S ElfellahJ L Reid
Jul 1, 1989·The Biochemical Journal·Y T Yang, M A McElligott
Feb 1, 1988·International Journal of Cardiology·D P LipkinP A Poole-Wilson
Apr 1, 1988·Sports Medicine·M A Van Baak
Jan 1, 1983·Advances in Experimental Medicine and Biology·P K SingalN S Dhalla
Nov 1, 1982·Canadian Journal of Physiology and Pharmacology·P K SingalN S Dhalla
Aug 1, 1995·Acta Physiologica Scandinavica·F BrunotteB Rajagopalan
Aug 1, 1994·British Heart Journal·A J CoatsP A Poole-Wilson
Oct 1, 1993·Journal of the American College of Cardiology·J S Floras
Aug 4, 1998·The American Journal of Physiology·S J PetersL L Spriet
Jun 15, 1999·Circulation·J K ShoemakerL I Sinoway
Mar 15, 2000·International Journal of Cardiology·J Niebauer
Aug 19, 2000·American Journal of Physiology. Endocrinology and Metabolism·L C NavegantesI C Kettelhut
May 15, 2001·European Heart Journal·S AdamopoulosD T Kremastinos
Jun 20, 2001·Acta Physiologica Scandinavica·P K LundeO M Sejersted
Jun 20, 2001·Acta Physiologica Scandinavica·M F PiepoliA J Coats

❮ Previous
Next ❯

Citations

Jan 10, 2018·Frontiers in Cellular Neuroscience·Luis F QuemeMichael P Jankowski
Nov 20, 2019·Journal of Cachexia, Sarcopenia and Muscle·Ligia M Antunes-CorreaCarlos Eduardo Negrão
Feb 23, 2019·Interventional Medicine & Applied Science·Igor Rabelo de FrançaAnderson Carlos Marçal
Sep 8, 2017·The Journal of Physiology·Tiago FernandesAndré C Silveira
Sep 28, 2018·Current Cardiology Reports·Mara PaneroniMassimo Venturelli
Jan 22, 2021·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Gohar AzharRobert R Wolfe
Apr 22, 2021·Cell Reports·Rodrigo W Alves de SouzaLeo E Otterbein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Related Papers

Heart Failure Clinics
Leonard A Kaminsky, Mary S Tuttle
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas
Patricia C BrumCarlos E Negrao
Life Sciences
Christiano Robles Rodrigues AlvesPatricia C Brum
© 2022 Meta ULC. All rights reserved